US Patent Litigations are now available. Check here
Explore detailed information on the case number ACT_10334/2025 involving Regeneron Pharmaceuticals Inc., Sanofi Biotechnology Sas and Amgen S.R.L., Amgen S.A.S., Amgen Nv, and others. Get insights into the proceedings, key dates, and all parties involved. Stay informed with the latest updates from IP Verse.
Case Details
Regeneron Pharmaceuticals Inc.
Sanofi Biotechnology Sas
Amgen S.R.L.
Amgen S.A.S.
Amgen Nv
Amgen Gmbh
Amgen Inc.
Amgen Europe B.V.
Amgen B.V.
Andras Kupecz
Berenice Thom
Ronny Thomas
Xavier DORLAND-GALLIOT
Case Decision
No decision available
More cases on Regeneron Pharmaceuticals Inc.
Sanofi-Aventis Groupe S.A.
Regeneron Pharmaceuticals Inc.
Sanofi Winthrop Industrie S.A.
Sanofi-Aventis Deutschland Gmbh
Amgen Inc.
Sanofi Biotechnologies Sas
Regeneron Pharmaceuticals Inc.
Amgen Inc.
Amgen Gmbh
Amgen Europe B.V.
Amgen Nv
Amgen S.R.L.
Amgen B.V.
Amgen S.A.S.
More cases on Amgen S.R.L.
Sanofi-Aventis Groupe S.A.
Regeneron Pharmaceuticals Inc.
Sanofi Winthrop Industrie S.A.
Sanofi-Aventis Deutschland Gmbh
Amgen Inc.
Alexion Pharmaceuticals
Amgen Technology (Ireland) Unlimited Company
Amgen N.V.
Amgen Gmbh
Amgen Ab
Amgen S.A.S.
Amgen S.R.L.
Amgen Biofarmaceutica Lda.
Amgen Zdravila D.O.O.